RE
INSIDER · IAM · Iambic Therapeutics, Inc. · DIRECTOR
Rachlin Evan Lockwood
Every open-market transaction filed under this name, Oct 16 to Oct 16.
Filings
1
1 buy · 0 sells
Bought
$11.5M
open market, at cost
Sold
—
includes scheduled sales
Buys since
—
no current price on file
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Oct 16 | IAM | Iambic Therapeutics, Inc. | Director | Buy | 718,750 | $16.00 | $11.5M | — |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.